Cesium
- Generic Name
- Cesium
- Drug Type
- Small Molecule
- Chemical Formula
- Cs
- CAS Number
- 7440-46-2
- Unique Ingredient Identifier
- 1KSV9V4Y4I
- Background
Cesium is under investigation in clinical trial NCT02794675 (Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer).
Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer
Early Phase 1
Completed
- Conditions
- Head and Neck CancerHead and Neck Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2016-06-09
- Last Posted Date
- 2020-12-23
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 15
- Registration Number
- NCT02794675
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer
Early Phase 1
Completed
- Conditions
- Recurrent Head and Neck Carcinoma
- Interventions
- First Posted Date
- 2015-06-10
- Last Posted Date
- 2025-05-20
- Target Recruit Count
- 30
- Registration Number
- NCT02467738
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath